SciNeuro is a biotechnology company focused on developing innovative medicines for patients with central nervous system diseases.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 8, 2020 | Series A | $100M | 2 | ARCH Venture Partners Lilly Asia Ventures | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
ARCH Venture Partners | Yes | Series A |
Lilly Asia Ventures | Yes | Series A |